Revolution Medicines, Inc. Common Stock

RVMDNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
149.60 USD
↗ 0.37 (0.25%)🟢LIVE (AS OF 12:13 PM EDT)
🟢Market: OPEN

RVMD is currently priced at $149.60. RVMD shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, RVMD is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 8, 2026.

Open?$150.10
High?$152.44
Low?$147.50
Prev. Close?$149.23
Volume?939.8K
Avg. Volume?2.9M
VWAP?$150.16
Rel. Volume?0.32x
Bid / Ask
Bid?$141.55 × 100
Ask?$157.31 × 100
Spread?$15.76
Midpoint?$149.43
Valuation & Ratios
Market Cap?31.7B
Shares Out?212.6M
Float?152.8M
Float %?79.0%
P/E Ratio?N/A
P/B Ratio?21.15
EPS?-$6.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Themes
Healthcare - Oncology›Targeted Therapy & Precision Oncology
Employees
883
Market Cap
31.7B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.revmed.com
Listed
2020-02-13
Address
700 SAGINAW DR
REDWOOD CITY, CA 94063
Phone: 650-481-6801
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
45
Piotroski F-Score?0/9Weak
Altman Z-Score?22.05Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.25%Elevated
Short Interest?11.1M
Days to Cover?4.7
Free Float152.8M
Avg Daily Volume2.3M
Settlement Date2026-05-15
Financial Health
Current Ratio?6.80Strong
Quick Ratio?6.80Strong
Cash Ratio?1.52Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
6
21.15HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-22.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-91.5%WEAK▾
ROA?
S&P
3
-60.9%WEAK▾
Cash Flow & Enterprise
FCF?$-1071733000
Enterprise Value?$31.3B
Fundamentals ratios updated end of day
MarketsMoversWatchlist